Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 12-2013 | |
| Sales | 251,000 | 0 | 270,000 | 293,000 | 0 |
| Cost of Goods | 24,000 | N/A | 25,000 | 26,000 | N/A |
| Gross Profit | 227,000 | N/A | 245,000 | 267,000 | N/A |
| Operating Expenses | 112,000 | 0 | 114,000 | 105,000 | 0 |
| Operating Income | 115,000 | N/A | 131,000 | 162,000 | N/A |
| Interest Expense | 13,000 | 0 | 0 | 0 | 0 |
| Pre-tax Income | 102,000 | 0 | 131,000 | 162,000 | 0 |
| Income Tax | 25,000 | N/A | 38,000 | 48,000 | N/A |
| Net Income Continuous | 77,000 | N/A | 93,000 | 114,000 | N/A |
| Net Income | $77,000 | $N/A | $93,000 | $114,000 | $N/A |
| EPS Basic Total Ops | 0.55 | N/A | 0.65 | 0.80 | N/A |
| EPS Basic Continuous Ops | 0.54 | N/A | 0.65 | 0.79 | N/A |
| EPS Diluted Total Ops | 0.55 | N/A | 0.65 | 0.80 | N/A |
| EPS Diluted Continuous Ops | 0.53 | N/A | 0.64 | 0.79 | N/A |
| EBITDA(a) | $121,000 | $N/A | $138,000 | $162,000 | $N/A |